Company Overview and News

5
Legacy Reserves: Not As Safe As You May Think

2018-09-22 seekingalpha
Legacy Reserves has been improving its situation via debt exchanges and the conversion to a C corporation.
SN LGCYP LGCYO LGCY SCAZP SNZYP

18
Analyzing A Top Energy ETF For Energy Plays

2018-09-21 seekingalpha - 1
If you had owned the SPDR S&P Oil & Gas Exploration ETF, you would have seen 30% in appreciation over the year ended 9/13/18 across 70 stocks.
CRC PBF STT LGCYP UPL LGCYO DNR CVX HFC LGCY REGI UPLMQ OXY

5
Legacy Reserves: This Is Getting Ridiculous

2018-09-20 seekingalpha
Despite oil prices soaring recently, shares of Legacy continue to find themselves under pressure despite generally good news and no real negative developments.
LGCYP LGCYO LGCY

5
ECA2018-160 - Information Regarding the Business Combination of Legacy Reserves (LGCY)

2018-09-20 nasdaqtrader
The business combination of Legacy Reserves LP (LGCY) with Legacy Reserves GP, LLC,. (the Partnership) has closed today, September 20, 2018. As a result, the Units Representing Limited Partner Interests (LGCY) will undergo a name, CUSIP number and issue type change effective on Friday, September 21, 2018. There is no change to the symbol. The Series A Preferred (LGCYP) & Series B Preferred (LGCYO) will be suspended from trading effective September 21, 2018.
LGCYP LGCYO LGCY

5
Legacy Reserves' Latest Big Move

2018-09-15 seekingalpha
The management team at Legacy Reserves surprised investors when, on September 14th, they announced a transaction that will eventually convert some debt into equity.
LGCYP LGCYO LGCY

5
Another Tale Of Insider Buying For Legacy Reserves

2018-09-07 seekingalpha
Almost every day for the past couple of weeks, Baines Creek Capital has purchased additional shares in Legacy.
LGCYP LGCYO LGCY

66
E&P Bottom Of The Barrel Club #18-4: The Second Half Kickoff Gets Muffed

2018-09-04 seekingalpha - 1
The 18 remaining companies in the Bottom of the Barrel Club recently reported 2Q results that were largely underwhelming overall.
ECR CRC APC PIO LGCYP LGCYO CRK DVN EPE SCAZP PIONF AXAS XTO MCEP ACTPF AREX MHRC EGC RXNRP REXXQ JNEEP SNZYP AST SN JGPK TALO BRMR SRCI MAGH JONE EOG DNR REXX BBG CHK CVX SGY LGCY HPR BRY AEUA

153
Stocks To Watch: Alibaba, Target And Energy Plays To Center Stage

2018-08-18 seekingalpha - 3
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
FOCS PDD LGCYP LGCYO QEP TJX EL AVGO ABBV FTNT KLXI CORR ESES SDPI TENB LNR RRS WPX FSBW ESTE NPTN ERF BABA SDCJF PAY MSFT GPS MPOYQ HRS FL MLM BLCN MOS SEA CLPS LB CLB ROSEU DBX CF CRDAF KSS CRDAD CI SSI JAG ROSE SNDE DAVA SJM UNT HUM EOG BHI RGRYY MU LGCY SBUX MNK WRD LOW JKS TOL LONE ERF CLB FTK AMAT CRD KEG KEGX SOXX STT FSWB WLL AQST SM LBRT BV LLEX ADIL NBR RGRLF CMG RRC INTU HIMX BJRI EDUC BE MPO ABBV BA ESRX ECR JG NDLS WPXP MTB RRL VMW ALRM LQDA RMBS ECA CANG ICD OPRA IBM WISA CDEV JGPK LYB COG ECA SPDI SBOW PHX TGT NTR BRY HPQ URBN TELL

8
Legacy Reserves: On Track For Success

2018-08-06 seekingalpha - 3
The management team at Legacy Reserves continues to deliver, with production growing nicely year over year and quarter over quarter.
LGCYP LGCYO LGCY

5
Legacy Reserves LP 2018 Q2 - Results - Earnings Call Slides

2018-08-02 seekingalpha
The following slide deck was published by Legacy Reserves LP in conjunction with their 2018 Q2 earnings call.
LGCYP LGCYO LGCY

15
Energy Week: What Now?

2018-07-28 seekingalpha - 3
We conclude our Beatles (8-day) Energy Week by asking our Marketplace panelists for the bottom line about oil, natural gas, and their favorite energy idea.
BTE HAL LGCYP LGCYO CJ CRLFF YGR GPRK VET SPE VET LGCY WTI YGRAF TTI PTORF

5
Legacy Reserves: Safer Than You Think

2018-07-25 seekingalpha
Given its leverage and how much a change in oil could impact its prospect, the business is risky but not as risky as some suggest.
LGCYP LGCYO LGCY

7
Legacy Reserves: A Reason To Be Optimistic

2018-07-13 seekingalpha - 2
Legacy has been one of the most volatile stocks through 2018, tossed higher and lower based on various news items.
LGCYP LGCYO LGCY

6
Transocean: Early Signs Of A Recovery

2018-07-11 seekingalpha - 1
The management team at Transocean announced the issuance of more debt that was among the lowest rate issued in recent years.
LGCYP LGCYO LGCY RIG

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...